Companion Diagnostics Industry, Global Share, Top 10 Leaders and Industry ForecaPosted by Shrikant Gadewar on January 23rd, 2020 Market Overview: Market Research Future (MRFR) expects the global companion diagnostics market to exhibit a robust 15.4% CAGR over the 2017 to 2023 forecast period to reach a valuation of more than USD 12 billion, according to the latest research report from the market research expert. The report provides a comprehensive overview of the global companion diagnostics market to readers looking to assess the growth prospects of the market and figure out which strategies are likely to work in the market in the coming years. Major drivers and restraints affecting the global companion diagnostics market are profiled in the report to help readers understand the major factors motivating the market in the coming years. Key competitive insights into the companion diagnostics market’s workings are also provided in the report on the back of a detailed analysis of the historical performance of companies in the global market. The field of companion diagnostics has boomed since the genetics revolution, as more in-depth information about a patient’s tendency to react to certain chemicals has been made available by genetic studies. Increasing availability of detailed information about a patient’s genetic makeup has allowed for the development of effective tests to cross-check various therapeutic products against the genetic tendencies exhibited by the patient. This has led to steady growth of the Companion Diagnostics Industry over the last few years. The increasing demand for personalized medicine in the coming years is likely to be a major driver for the companion diagnostics market. As the genetics field has grown, physicians and medical researchers have been quick to make use of it to develop ways of treating diseases with highly personalized, customized treatment formulations that best suit the individual patient in question. Competitive Analysis:
Segmentation:
Regional Analysis: The Americas is likely to remain the major revenue generator in the global companion diagnostics market over the forecast period, followed by Europe and Asia Pacific. North America is likely to remain the leading regional market due to the growing presence of the healthcare sector and the strong presence of research avenues into genetics. Asia Pacific is likely to exhibit the highest growth rate. Like it? Share it!More by this author |